Contact this trialFirst, we need to learn more about you.
Insulin
Insulin glargine +1 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Troy, Michigan
This trial compares a new weekly insulin to a daily insulin that is already on the market, in people with type 2 diabetes. It will look at how well the weekly insulin controls blood sugar compared to the daily insulin. The study will last for about 1 ½ years, with 37 clinic visits and 26 phone calls with the study doctor.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.